494 related articles for article (PubMed ID: 12519413)
1. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
2. Galanin in human pituitary adenomas: frequency and clinical significance.
Leung B; Iisma TP; Leung KC; Hort YJ; Turner J; Sheehy JP; Ho KK
Clin Endocrinol (Oxf); 2002 Mar; 56(3):397-403. PubMed ID: 11940053
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of silent corticotroph adenomas.
Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
[TBL] [Abstract][Full Text] [Related]
4. A spectrum of behaviour in silent corticotroph pituitary adenomas.
Baldeweg SE; Pollock JR; Powell M; Ahlquist J
Br J Neurosurg; 2005 Feb; 19(1):38-42. PubMed ID: 16147581
[TBL] [Abstract][Full Text] [Related]
5. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M
Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459
[TBL] [Abstract][Full Text] [Related]
6. ACTH adenomas transforming their clinical expression: report of 5 cases.
Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
[TBL] [Abstract][Full Text] [Related]
7. Silent corticotroph adenomas.
Karavitaki N; Ansorge O; Wass JA
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1314-8. PubMed ID: 18209869
[TBL] [Abstract][Full Text] [Related]
8. Silent corticotroph adenomas.
Ben-Shlomo A; Cooper O
Pituitary; 2018 Apr; 21(2):183-193. PubMed ID: 29344907
[TBL] [Abstract][Full Text] [Related]
9. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
10. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience.
Erickson D; Scheithauer B; Atkinson J; Horvath E; Kovacs K; Lloyd RV; Young WF
Clin Endocrinol (Oxf); 2009 Jul; 71(1):92-9. PubMed ID: 19170710
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
12. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
[TBL] [Abstract][Full Text] [Related]
13. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
[TBL] [Abstract][Full Text] [Related]
14. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study.
Turner HE; Stratton IM; Byrne JV; Adams CB; Wass JA
Clin Endocrinol (Oxf); 1999 Sep; 51(3):281-4. PubMed ID: 10469006
[TBL] [Abstract][Full Text] [Related]
15. Corticotroph pituitary carcinoma with skeletal metastases masquerading as ectopic ACTH syndrome: a long and winding road to diagnosis.
Van Mieghem E; Intan-Goey V; Buffet W; Lammens M; Van Loo P; Abrams P
Endocrinol Diabetes Metab Case Rep; 2022 Mar; 2022():. PubMed ID: 35319488
[TBL] [Abstract][Full Text] [Related]
16. Clinically silent corticotroph tumors of the pituitary gland.
Scheithauer BW; Jaap AJ; Horvath E; Kovacs K; Lloyd RV; Meyer FB; Laws ER; Young WF
Neurosurgery; 2000 Sep; 47(3):723-9; discussion 729-30. PubMed ID: 10981760
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
[TBL] [Abstract][Full Text] [Related]
18. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
George DH; Scheithauer BW; Kovacs K; Horvath E; Young WF; Lloyd RV; Meyer FB
Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
[TBL] [Abstract][Full Text] [Related]
20. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
